A Phase III Clinical Study of KW-2246 for Breakthrough Pain in Cancer Patients

NCT00684632 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain, Cancer

Interventions

DRUG: Placebo
DRUG: KW-2246 (fentanyl citrate)

Sponsor

Kyowa Kirin Co., Ltd.